1. G. Camussi, I. Pawlowski, C. Tetta, C. Roffinello, M. Alberton, J. Brentjens and G. Andres,Acute lung inflammation induced in the rabbit by local instillation of 1-0-Octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor, Am. J. Pathol.112, 78–88 (1983).
2. A. J. Wardlow and A. B. Kay,Paf-acether is a potent chemotactic for human eosinophils, J. All. Clin. Immunol.88, Suppl., 463 (1986).
3. K. F. Chung, H. Aizawa, G. D. Leikauf, J. F. Euki, T. W. Evans and J. A. Nadel,Airways hyperresponsiveness induced by platelet activating factor: role of thromboxane generation, J. Pharmacol. Expl. Therap.236, 580–584 (1986).
4. F. M. Cuss, C. M. Dixon and P. J. Barnes,Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancetii, 189–192 (1986).
5. M. F. Fitzgerald, S. Moncada and L. Parente,The release of Paf-acether and lyso-Paf from sensitized guinea-pig lungs, Brit. J. Pharmacol. 86, 573P (1985).